#None #Edinburgh #Bioinformatics #Fios Genomics #Excelra

Excelra Welcomes Fios Genomics Bioinformatics Team

In a significant move set to enhance its scientific consulting capabilities, Excelra has announced the integration of Fios Genomics Ltd’s bioinformatics team and services. This transition, effective from October 20, 2026, marks a strategic step towards expanding Excelra's expertise in the field of omics analytics across the UK and Europe.

Fios Genomics, renowned for its ability to transform complex omics data into actionable insights for the pharmaceutical, biotech, and life science research sectors, has built a robust reputation over nearly two decades. Their expertise, particularly in the analysis of multi-omics studies, has proven invaluable in providing in-depth insights that facilitate innovative research.

The integration of the Fios team into Excelra’s broader scientific consulting group signifies a commitment to enhancing customer benefits while maintaining continuity in service. Sarah Lynagh, CEO of Fios Genomics, emphasized that the quality of scientific work and the attention given to each study have always been the core values of Fios. She noted that Excelra shares these values and brings more extensive competencies in data science and scientific informatics to the table.

Jannick Bendtsen, Vice President of Bioinformatics at Excelra, expressed confidence in the partnership, highlighting that Fios is celebrated for delivering rigorous, study-level analyses - attributes that researchers greatly depend on when receiving a dataset. The collaborative approach aligns seamlessly with Excelra's focus on integrative multi-omics, translational insights, and scientific AI. The Fios team will now have access to robust datasets, expertise in AI development, and a greater pool of specialists to draw from, enabling them to enhance their capabilities further.

Anandbir Singh Brar, CEO of Excelra, welcomed the Fios team warmly, stating, "Fios has nurtured a group of bioinformaticians that clients trust with their most challenging inquiries. With the ever-increasing volume of data in the realm of omics technologies, the critical questions remain: What is the target? Which indication? Which patients? By merging Fios's scientific expertise with our bioinformatics, data, and AI-driven development, we can address these questions more swiftly and confidently."

Fios customers can continue to reach the team at their established contact. This merger not only signifies growth but also emphasizes the importance of research integrity and innovative solutions in scientific challenges.

About Excelra

Excelra focuses on AI-driven research and development, leveraging AI-enabled data and platforms—including GOSTAR, integrated laboratory informatics, and multi-omics expertise—to navigate the complexities of research and development into defendable decisions.

About Fios Genomics

Founded in 2008 as a spin-off from the University of Edinburgh, Fios Genomics has been at the forefront of providing bioinformatics analysis and biological interpretations across genomics, transcriptomics, and multi-omics studies for global pharmaceutical, biotech, and life science researchers. By transitioning to Excelra, Fios aims to amplify its scientific impact and deliver enhanced services to its clientele.